<code id='DE96512A03'></code><style id='DE96512A03'></style>
    • <acronym id='DE96512A03'></acronym>
      <center id='DE96512A03'><center id='DE96512A03'><tfoot id='DE96512A03'></tfoot></center><abbr id='DE96512A03'><dir id='DE96512A03'><tfoot id='DE96512A03'></tfoot><noframes id='DE96512A03'>

    • <optgroup id='DE96512A03'><strike id='DE96512A03'><sup id='DE96512A03'></sup></strike><code id='DE96512A03'></code></optgroup>
        1. <b id='DE96512A03'><label id='DE96512A03'><select id='DE96512A03'><dt id='DE96512A03'><span id='DE96512A03'></span></dt></select></label></b><u id='DE96512A03'></u>
          <i id='DE96512A03'><strike id='DE96512A03'><tt id='DE96512A03'><pre id='DE96512A03'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:135
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          UCB departs biotech trade group BIO
          UCB departs biotech trade group BIO

          AdobeWASHINGTON— UCBleftBIOattheendof2023,thesecondmajormembercompanytoexitafterPfizerpulledoutaswel

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          After half a century, Israel moves to evict squatter from his cave home on the beach

          A"welcomehome"blessingmadeofstonesitsatNissimKahlon'shomechiseledoutofthesandstonecliffsoverlookingt